DK Life Science Co., Ltd. (KOSDAQ:303810)
3,535.00
-100.00 (-2.75%)
At close: Jan 30, 2026
DK Life Science Revenue
DK Life Science had revenue of 29.44B KRW in the quarter ending September 30, 2025, a decrease of -9.17%. This brings the company's revenue in the last twelve months to 131.17B, up 0.95% year-over-year. In the year 2024, DK Life Science had annual revenue of 131.82B with 9.70% growth.
Revenue (ttm)
131.17B
Revenue Growth
+0.95%
P/S Ratio
0.86
Revenue / Employee
1.31B
Employees
100
Market Cap
113.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.82B | 11.65B | 9.70% |
| Dec 31, 2023 | 120.16B | 12.93B | 12.05% |
| Dec 31, 2022 | 107.23B | 4.57B | 4.45% |
| Dec 31, 2021 | 102.67B | -6.91B | -6.31% |
| Dec 31, 2020 | 109.58B | 10.97B | 11.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.56T |
| Celltrion | 3.90T |
| Jeil Pharma Holdings | 707.15B |
| ALTEOGEN | 202.18B |
| CKD Bio | 159.93B |
| ABL Bio | 88.44B |
| Aprogen Biologics | 74.91B |
| Enzychem Lifesciences | 72.17B |